Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

XPhyto: Innovating a Therapeutic Psychedelic Drug Pipeline

It’s been dubbed the Age of Anxiety. Yet it’s quickly becoming far worse than that. With the arrival of globalism, the new millennium has already become synonymous with the threat of deadly pandemics. And the onslaught of the worst of them s...
Marc Davis | January 20, 2021 |

The ‘Lean Mean Fighting Machine’ That’s Redefining the Cannabis 2.0 Marketplace

The rubber has finally hit the road for Cannabis 2.0. And conventional wisdom says it's the infused beverage market to be the engine that will drive it. Hill Street Beverage Company Inc . ( TSX-V.BEER , OTCQB: HSEEF , Forum ) boasts some of the infused beverage sector&...
Dave Jackson | June 15, 2020 |

Biopharma Makes Licensing Deal for Therapeutic Rights in Japan

The company's reasons for the transaction and expected short-term, stock-moving events are provided in a ROTH Capital Partners report. In a Sept. 9 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Eidos Therapeutics Inc. (EIDX:NASDAQ) agreed...
Streetwise Reports | September 12, 2019 |

Biotech's DMD Therapeutic 'Solidifies the Ground for Potential Pivotal Design'

The latest development concerning this clinical asset and other Q2/19 highlights are provided in an H.C. Wainwright & Co. report. In an Aug. 8 research note, analyst Joseph Pantginis reviewed Capricor Therapeutics Inc.'s (CAPR:NASDAQ) Q2/19 financials and reported t...
Streetwise Reports | August 14, 2019 |

There’s More Upside in Gold & Gold Stocks

After a major trend change, it can be difficult for the majority of investors and market watchers to shift and adjust accordingly to the new trend. It's no different in the current case of precious metals which, other than a huge rally in the first half of 2016 have bee...
Jordan Roy-Byrne, CMT | August 7, 2019 |

XPhyto: The Cutting Edge of Medical Cannabis Science

At the forefront of the next wave of cannabis commercialization, is a German-focused company with headquarters in Vancouver, XPhyto Therapeutics Corp. (CSE: XPHY; FSE: 4XT) , that is building a much-coveted cannabis R&D cultivation facility in a converted nuclear bunker and o...
Marc Davis | November 12, 2019 |

InMed Shares Trade Up 25% After Becoming First to Advance Cannabinol into Clinical Trials

InMed Pharmaceuticals shares traded 25% higher after reporting that it is the first to advance cannabinol into therapeutic clinical trials. Vancouver-based clinical stage biopharmaceutical company InMed Pharmaceuticals Inc. (IN:TSX; IMLFF:OTCQX) , which is engaged in...
Streetwise Reports | January 21, 2020 |

Gold and Lagarde – Friends or Foes?

A week ago, Lagarde chaired the monetary policy meeting of the Governing Council of the ECB for the first time. An insightful press conference followed in the footsteps. What will her presidency imply for the ECB’s policy and the gold market precisely? Key T...
Arkadiusz Sieron | December 20, 2019 |

Pursuing silver and gold acquisitions from a position of strength

Silvercorp Metals Inc. has developed a knack for replicating a profitable mining strategy globally By Peter Kenter Every precious metal mining company is looking for the next great gold or silver property. Silvercorp Metals Inc. ( TSX:SVM / NYSEAM: SVM ) is no...
Research | January 30, 2023 |

Karuna Shares Jump 375% Higher on Phase 2 Acute Psychosis Treatment Trial Data

Shares of Karuna Therapeutics, which completed an IPO in July 2019, soared more than 375% higher today after the firm reported that its KarXT met primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia. This morning clinical-stag...
Streetwise Reports | November 19, 2019 |
1 2 3 4 5 6 7 8 9 10 ...